Phio Pharmaceuticals Announces "Nobel Prize Winning Science Takes on Skin Cancer" in a Fireside Chat with Force Family Office on Wednesday, April 15, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - April 13, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using it
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-04-13 7:00 AM EDT | Phio Pharmaceuticals Corp.
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 13, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that the Company will be participating as a presenting company at the 2026 Bloom Burton & Co. Healthcar
Technology, Biotechnology, Investment Banking, Health
2026-04-13 7:00 AM EDT | Bloom Burton & Co. Inc.
UberDoc Health Technologies Corp. Announces Upcoming Investor Webinar
Boston, Massachusetts--(Newsfile Corp. - April 13, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) ("UberDoc" or the "Company") is pleased to announce that Sean Kearney, Chief Executive Officer, and Dr. Paula Muto, Founder and Chief Medical Advisor, will present an introduction to UberDoc in a live investor webinar taking place on Wednesday, April 15, 2026, at 11:00 AM PT / 2:00 PM ET.
2026-04-13 1:00 AM EDT | UberDoc
Voting Results of Cosmo's 2026 AGM
Dublin, Ireland--(Newsfile Corp. - April 10, 2026) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announced that its shareholders approved all voting items at today’s Ordinary Annual General Meeting (AGM). A total of 10,354,065 ordinary shares of the share capital of Cosmo were represented at this general meeting of shareholders. These shares make up 59.02% of the total outstanding ordinary shares in the share capital of Cosmo as of the record
Healthcare and Hospitals, Health
2026-04-10 9:16 AM EDT | Cosmo Pharmaceuticals N.V.
Safe Supply Streaming Co Ltd. Reports Results of Annual General and Special Meeting of Shareholders
Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company") reports that its Annual General and Special Meeting of Shareholders (the "Meeting") was held on April 8, 2026 in Toronto, Ontario. The following is a summary of the voting results for each matter put before shareholders at the Meeting. Meeting Results The following resolutions were voted on and approv
2026-04-10 7:03 AM EDT | Safe Supply Streaming Co Ltd.
AtomVie Global Radiopharma to Present at The Bloom Burton & Co. Healthcare Investor Conference 2026
Hamilton, Ontario--(Newsfile Corp. - April 9, 2026) - AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing for clinical and commercial supply of radiopharmaceuticals and their worldwide distribution, is pleased to announce that they will be presenting at the Bloom Burton & Co. Healthcare Investor Conference (BBHIC) 2026, taking place at the Metro Convention Centre in Toronto,
Technology, Biotechnology, Investment Banking, Health
2026-04-09 10:00 AM EDT | Bloom Burton & Co. Inc.
Akanda Corp. Announces Reverse Stock Split
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it expects to implement a 1-for-4.5 reverse stock split of the Company's common shares effective April 13, 2026. The reverse stock split was previously approved by the Company's shareholders on November 28, 2025 and Board of Directors on March 23, 2026 and will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market on
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-04-09 8:30 AM EDT | Akanda Corp
FloraWorks Announces TruCBN(TM) Readiness for the CMS Substance Access BEI Program with Full Clinical and Safety Substantiation
Portland, Oregon--(Newsfile Corp. - April 9, 2026) - FloraWorks today announced that TruCBN™ 50 mg softgels are available to healthcare organizations evaluating sleep-focused hemp products for the CMS Substance Access Beneficiary Engagement Incentive (BEI) program. In a published 1,020-person randomized, double-blind, placebo-controlled clinical trial, TruCBN™ 50 mg dose demonstrated statistically significant improvement in sleep quality. Real-world evidence has
Technology, Cannabis, Health, Cannabis Manufacturer
2026-04-09 8:00 AM EDT | FloraWorks
Cheelcare Delivers First Curio Robotic Complex-Rehab Power Wheelchair to Paying Customers and Achieves Record Companion Sales
Markham, Ontario--(Newsfile Corp. - April 9, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, today announced the delivery of its first Curio robotic complex-rehab power wheelchair to paying customers, marking the Company's transition into commercial production and initial revenue generation for its flagship power wheelchair platform. This milestone is complemented by record Companion unit sales in Marc
2026-04-09 7:30 AM EDT | Cheelcare Inc.
Promino Nutritional Sciences Launches NCAA Division I Athlete Platform Through Multi-Sport NIL Partnership with Virginia Military Institute
Burlington, Ontario--(Newsfile Corp. - April 9, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a developer of advanced proprietary amino acid formulations for muscle health, today announced a multi-sport Name, Image and Likeness ("NIL") partnership with eight NCAA Division I student-athletes at the Virginia Military Institute ("VMI"). This agreement marks the formal launch of the Promino NCAA Athlete Platform, a strategic ini
Food / Beverages, Sports, Health
2026-04-09 7:00 AM EDT | Promino Nutritional Sciences, Inc.
Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - April 9, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Robert Bitterman, Chief Executive Officer and Chairman of the Board, will present at the Centri Capital Conference on Tuesday, April 14, 2026, at Nasdaq Marketsite in New York City. The present
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-04-09 7:00 AM EDT | Phio Pharmaceuticals Corp.
Conavi Medical to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO of Conavi Medical, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference to be held Apr
Technology, Biotechnology, Investment Banking, Health
2026-04-09 7:00 AM EDT | Bloom Burton & Co. Inc.
CORRECTION FROM SOURCE: UberDoc to Participate in Hint Summit 2026, Introducing Specialty Referral Program for Direct Primary Care Physicians
Boston, Massachusetts--(Newsfile Corp. - April 8, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) ("UberDoc" or the "Company"), an innovative healthcare platform empowering patients to connect with top physicians directly and without the wait, today announced its participation in Hint Summit 2026, taking place April 8-11 at the Country Music Hall of Fame in Nashville, Tennessee. At the conference,
2026-04-08 6:47 PM EDT | UberDoc
Custom Health to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Kelowna, British Columbia--(Newsfile Corp. - April 8, 2026) - Custom Health Inc. ("Custom Health" or the "Company"), a vertically integrated, tech-enabled care platform, is pleased to announce that the Company will be participating as a presenting company at the 2026 Bloom Burton & Co. Healthcare Investor Conference. Shane Bishop, Chief Executive Officer, will be presenting and will also be hosting one-on-one meetings with investors throughout the conference.
Technology, Biotechnology, Investment Banking, Health
2026-04-08 2:10 PM EDT | Bloom Burton & Co. Inc.
MyndTec Inc. Announces Inability to Secure Financing, Cessation of Operations and Evaluation of Strategic Alternatives Including Insolvency Proceedings
Mississauga, Ontario--(Newsfile Corp. - April 8, 2026) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company") announces that it has been unable to secure the additional financing required to continue operations. As previously disclosed, the Company's operations during 2024 and 2025 were substantially funded by its principal shareholder, Jim Anderson, through his participation in successive private placement offerings. Mr. Anderson has confirmed that he will not be mak
Technology, Healthcare and Hospitals, Health
2026-04-08 12:17 PM EDT | MyndTec Inc.
Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc.
North Bergen, New Jersey--(Newsfile Corp. - April 8, 2026) - Apollo Biowellness, Inc. (OTCID: KOAN) (the "Company" or "Apollo"), in conjunction with the final due diligence being reviewed by MedwellAI, Inc. (OTCQB: MWAI) to acquire Apollo and its subsidiaries including Evolutionary Biologics, Inc. ("Evo Bio"), (the "Transaction"), MWAI has reserved a Preferred Series B class of stock for the share exchanged and assumption of certain liabilities of Apollo. Negotiations are ongoing with
Household / Consumer / Cosmetics, Health
2026-04-08 9:30 AM EDT | Apollo Biowellness, Inc.
Adia Nutrition Strikes Major Partnership with Leading Atlanta Clinic to Launch Groundbreaking Autism Clinical Study
Winter Park, Florida--(Newsfile Corp. - April 8, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced a strategic partnership with a prominent clinic in Atlanta, Georgia. Adia Labs will serve as the exclusive supplier of regenerative products for the clinic's new Autism Spectrum Disorder (ASD) clinical study. This partnership is a key part of Adia Nutrition's 2026 plan to build solid scientific evidence for regenerative therapies that have the potenti
Healthcare and Hospitals, Health
2026-04-08 8:30 AM EDT | Adia Nutrition Inc.
UberDoc to Participate in Hint Summit 2026, Introducing Specialty Referral Program for Direct Primary Care Physicians
Boston, Massachusetts--(Newsfile Corp. - April 8, 2026) - UberDoc Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) ("UberDoc" or the "Company"), an innovative healthcare platform empowering patients to connect with top physicians directly and without the wait, today announced its participation in Hint Summit 2026, taking place April 8-11 at the Country Music Hall of Fame in Nashville, Tennessee. At the conference,
2026-04-08 8:30 AM EDT | UberDoc
The Obesity Medicine Association Hosts Obesity Medicine 2026: The Heart of Obesity Care
Denver, Colorado--(Newsfile Corp. - April 8, 2026) - The Obesity Medicine Association (OMA), the nation's oldest medical society dedicated exclusively to obesity treatment, will host its annual conference, Obesity Medicine 2026: The Heart of Obesity Care, April 10-12 in San Diego, California. Bringing together more than 1,500 clinicians, researchers, and industry leaders, the conference highlights the latest science, clinical strategies, and innovations shaping the future of obesity med
Healthcare and Hospitals, Health
2026-04-08 8:00 AM EDT | Obesity Medicine Association
Glow Lifetech Reports Fourth Quarter and Full Year 2025 Financial Results; 146% YoY Revenue Growth and Second Consecutive Quarter of Positive Cash Flow
Toronto, Ontario--(Newsfile Corp. - April 8, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth quarter and full year ended December 31, 2025 ("Q4 2025" and "FY 2025"). In FY 2025, Glow delivered record revenue and gross profit, sustained high gross margins, improved operating efficiency, and strengthened its balance sheet while achieving its second consecutive quarter of positive
2026-04-08 7:30 AM EDT | Glow Lifetech Corp.